- Home
- KRUS vs BDTX Comparison
KRUS vs BDTX Comparison
Compare KRUS & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRUS
- BDTX
- Stock Information
- Founded
- KRUS 2008
- BDTX 2014
- Country
- KRUS United States
- BDTX United States
- Employees
- KRUS N/A
- BDTX N/A
- Industry
- KRUS Restaurants
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRUS Consumer Discretionary
- BDTX Health Care
- Exchange
- KRUS Nasdaq
- BDTX Nasdaq
- Market Cap
- KRUS 990.5M
- BDTX 132.5M
- IPO Year
- KRUS 2019
- BDTX 2020
- Fundamental
- Price
- KRUS $82.01
- BDTX $2.61
- Analyst Decision
- KRUS Buy
- BDTX Strong Buy
- Analyst Count
- KRUS 9
- BDTX 6
- Target Price
- KRUS $76.78
- BDTX $14.83
- AVG Volume (30 Days)
- KRUS 276.5K
- BDTX 1.2M
- Earning Date
- KRUS 07-08-2025
- BDTX 08-05-2025
- Dividend Yield
- KRUS N/A
- BDTX N/A
- EPS Growth
- KRUS N/A
- BDTX N/A
- EPS
- KRUS N/A
- BDTX 0.09
- Revenue
- KRUS $258,444,000.00
- BDTX $70,000,000.00
- Revenue This Year
- KRUS $19.52
- BDTX N/A
- Revenue Next Year
- KRUS $18.63
- BDTX N/A
- P/E Ratio
- KRUS N/A
- BDTX $28.49
- Revenue Growth
- KRUS 21.37
- BDTX N/A
- 52 Week Low
- KRUS $40.03
- BDTX $1.20
- 52 Week High
- KRUS $110.66
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- KRUS 53.42
- BDTX 59.61
- Support Level
- KRUS $79.15
- BDTX $2.43
- Resistance Level
- KRUS $91.14
- BDTX $2.72
- Average True Range (ATR)
- KRUS 4.30
- BDTX 0.17
- MACD
- KRUS -0.39
- BDTX -0.01
- Stochastic Oscillator
- KRUS 35.99
- BDTX 75.77
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.